Amgen Inc.
Cash Flow Statement
| Line Item | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 |
|---|---|---|---|---|---|---|---|---|
| Operating Activities | ||||||||
| Net Income | $7.71B | $4.09B | $6.72B | $6.55B | $5.89B | $7.26B | $7.84B | $8.39B |
| Depreciation & Amortization | $5.17B | $5.59B | $4.07B | $3.42B | $3.40B | $3.60B | $2.21B | $1.95B |
| Depreciation | $763.0M | $694.0M | $685.0M | $661.0M | $644.0M | $640.0M | $635.0M | $630.0M |
| Amortization | $4.30B | $4.80B | $3.20B | $2.60B | $2.60B | $2.80B | $1.40B | $1.30B |
| Stock-Based Compensation | $494.0M | $530.0M | $431.0M | $401.0M | $341.0M | $330.0M | $308.0M | $311.0M |
| Net Cash from Operating Activities | $9.96B | $11.49B | $8.47B | $9.72B | $9.26B | $10.50B | $9.15B | $11.30B |
| Investing Activities | ||||||||
| Capital Expenditures | $1.86B | $1.10B | $1.11B | $936.0M | $880.0M | $608.0M | $618.0M | $738.0M |
| Business Acquisitions | $53.0M | $0 | $26.99B | $3.84B | $2.53B | $0 | $13.62B | $-195.0M |
| Net Cash from Investing Activities | $-1.94B | $-1.05B | $-26.20B | $-6.04B | $733.0M | $-5.40B | $5.71B | $14.34B |
| Financing Activities | ||||||||
| Dividends Paid | $5.12B | $4.83B | $4.56B | $4.20B | $4.01B | $3.76B | $3.51B | $3.51B |
| Stock Repurchases | $0 | $200.0M | $0 | $6.36B | $4.98B | $3.49B | $7.70B | $17.79B |
| Net Cash from Financing Activities | $-10.86B | $-9.42B | $21.05B | $-4.04B | $-8.27B | $-4.87B | $-15.77B | $-22.49B |
| Net Change in Cash | $-2.84B | $1.03B | $3.32B | $-360.0M | $1.72B | $229.0M | $-908.0M | $3.15B |
| Free Cash Flow | $8.10B | $10.39B | $7.36B | $8.79B | $8.38B | $9.89B | $8.53B | $10.56B |